Recent advances in the detection of ovarian cancer: A review

Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor disseminat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Osteopathic Medicine (Online) 1994-04, Vol.94 (4), p.305-305
Hauptverfasser: Blend, Michael J., Ostrowski, Gregory J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 305
container_issue 4
container_start_page 305
container_title Journal of Osteopathic Medicine (Online)
container_volume 94
creator Blend, Michael J.
Ostrowski, Gregory J.
description Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used.
doi_str_mv 10.7556/jaoa.1994.94.4.305
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76589720</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76589720</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2515-229d143a63cfadd8ae6cc86ea502d94ab458838c9a1ad93cd59597a04d34901c3</originalsourceid><addsrcrecordid>eNp9kFtLAzEQhYMoWqp_QBDy5NvWXHcT8UEp3kAQRJ_DmEx1S7tbk92W_nuztPgoDMzAnDmH-Qg552xSaV1ezaGFCbdWTXKpiWT6gIxExUQhS2UOyYgxa4qSa35CzlKaM8aE5lIIfkyODROltXZEbt7QY9NRCGtoPCZaN7T7RhqwQ9_VbUPbGW3XEGtoqB8k8Zre0YjrGjen5GgGi4Rn-z4mHw_379On4uX18Xl691L4nKgLIWzgSkIp_QxCMICl96ZE0EwEq-BTaWOk8RY4BCt90FbbCpgKUlnGvRyTy53vKrY_PabOLevkcbGABts-uarUxlaCZaHYCX1sU4o4c6tYLyFuHWduoOYGam6g5nIpl6nlo4u9e_-5xPB3smeU97e7_QYWHcaAX7Hf5sHN2z42-e9_zK1SQ8Qv26h8tw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76589720</pqid></control><display><type>article</type><title>Recent advances in the detection of ovarian cancer: A review</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Blend, Michael J. ; Ostrowski, Gregory J.</creator><creatorcontrib>Blend, Michael J. ; Ostrowski, Gregory J.</creatorcontrib><description>Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used.</description><identifier>ISSN: 0098-6151</identifier><identifier>ISSN: 2702-3648</identifier><identifier>EISSN: 2702-3648</identifier><identifier>DOI: 10.7556/jaoa.1994.94.4.305</identifier><identifier>PMID: 8026999</identifier><language>eng</language><publisher>United States: American Osteopathic Association</publisher><subject>Antibodies, Monoclonal ; Biomarkers, Tumor - blood ; Diet ; Family Health ; Female ; Humans ; Magnetic Resonance Imaging ; Mass Screening ; Neoplasm Staging ; Ovarian Neoplasms - diagnosis ; Ovarian Neoplasms - etiology ; Ovarian Neoplasms - mortality ; Ovarian Neoplasms - therapy ; Physical Examination ; Prognosis ; Radioimmunodetection ; Risk Factors ; Survival Rate ; Tomography, X-Ray Computed</subject><ispartof>Journal of Osteopathic Medicine (Online), 1994-04, Vol.94 (4), p.305-305</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8026999$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blend, Michael J.</creatorcontrib><creatorcontrib>Ostrowski, Gregory J.</creatorcontrib><title>Recent advances in the detection of ovarian cancer: A review</title><title>Journal of Osteopathic Medicine (Online)</title><addtitle>J Am Osteopath Assoc</addtitle><description>Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used.</description><subject>Antibodies, Monoclonal</subject><subject>Biomarkers, Tumor - blood</subject><subject>Diet</subject><subject>Family Health</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Mass Screening</subject><subject>Neoplasm Staging</subject><subject>Ovarian Neoplasms - diagnosis</subject><subject>Ovarian Neoplasms - etiology</subject><subject>Ovarian Neoplasms - mortality</subject><subject>Ovarian Neoplasms - therapy</subject><subject>Physical Examination</subject><subject>Prognosis</subject><subject>Radioimmunodetection</subject><subject>Risk Factors</subject><subject>Survival Rate</subject><subject>Tomography, X-Ray Computed</subject><issn>0098-6151</issn><issn>2702-3648</issn><issn>2702-3648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFtLAzEQhYMoWqp_QBDy5NvWXHcT8UEp3kAQRJ_DmEx1S7tbk92W_nuztPgoDMzAnDmH-Qg552xSaV1ezaGFCbdWTXKpiWT6gIxExUQhS2UOyYgxa4qSa35CzlKaM8aE5lIIfkyODROltXZEbt7QY9NRCGtoPCZaN7T7RhqwQ9_VbUPbGW3XEGtoqB8k8Zre0YjrGjen5GgGi4Rn-z4mHw_379On4uX18Xl691L4nKgLIWzgSkIp_QxCMICl96ZE0EwEq-BTaWOk8RY4BCt90FbbCpgKUlnGvRyTy53vKrY_PabOLevkcbGABts-uarUxlaCZaHYCX1sU4o4c6tYLyFuHWduoOYGam6g5nIpl6nlo4u9e_-5xPB3smeU97e7_QYWHcaAX7Hf5sHN2z42-e9_zK1SQ8Qv26h8tw</recordid><startdate>19940401</startdate><enddate>19940401</enddate><creator>Blend, Michael J.</creator><creator>Ostrowski, Gregory J.</creator><general>American Osteopathic Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940401</creationdate><title>Recent advances in the detection of ovarian cancer: A review</title><author>Blend, Michael J. ; Ostrowski, Gregory J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2515-229d143a63cfadd8ae6cc86ea502d94ab458838c9a1ad93cd59597a04d34901c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Antibodies, Monoclonal</topic><topic>Biomarkers, Tumor - blood</topic><topic>Diet</topic><topic>Family Health</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Mass Screening</topic><topic>Neoplasm Staging</topic><topic>Ovarian Neoplasms - diagnosis</topic><topic>Ovarian Neoplasms - etiology</topic><topic>Ovarian Neoplasms - mortality</topic><topic>Ovarian Neoplasms - therapy</topic><topic>Physical Examination</topic><topic>Prognosis</topic><topic>Radioimmunodetection</topic><topic>Risk Factors</topic><topic>Survival Rate</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blend, Michael J.</creatorcontrib><creatorcontrib>Ostrowski, Gregory J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Osteopathic Medicine (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blend, Michael J.</au><au>Ostrowski, Gregory J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances in the detection of ovarian cancer: A review</atitle><jtitle>Journal of Osteopathic Medicine (Online)</jtitle><addtitle>J Am Osteopath Assoc</addtitle><date>1994-04-01</date><risdate>1994</risdate><volume>94</volume><issue>4</issue><spage>305</spage><epage>305</epage><pages>305-305</pages><issn>0098-6151</issn><issn>2702-3648</issn><eissn>2702-3648</eissn><abstract>Epithelial ovarian cancer is one of the more aggressive malignancies among American women today, and its incidence is increasing. The major obstacle in combatting ovarian cancer is the remarkable lack of symptoms in early-stage disease. Symptoms usually occur in advanced stages when tumor dissemination within the peritoneal cavity induces ascites with resultant increasing abdominal girth. Physicians have been unable to reach women who have early-stage ovarian cancer, a time when a high cure rate could be expected. However, during the past few years, significant developments in the areas of serum tumor markers, transvaginal ultrasonography with color flow Doppler analysis, immunodiagnostic techniques, and immunotherapy have been reported. These new modalities show promise for use in the early diagnosis and treatment of ovarian cancer. The authors review some of the new data and discuss patient outcomes when these new modalities are used.</abstract><cop>United States</cop><pub>American Osteopathic Association</pub><pmid>8026999</pmid><doi>10.7556/jaoa.1994.94.4.305</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0098-6151
ispartof Journal of Osteopathic Medicine (Online), 1994-04, Vol.94 (4), p.305-305
issn 0098-6151
2702-3648
2702-3648
language eng
recordid cdi_proquest_miscellaneous_76589720
source MEDLINE; Alma/SFX Local Collection
subjects Antibodies, Monoclonal
Biomarkers, Tumor - blood
Diet
Family Health
Female
Humans
Magnetic Resonance Imaging
Mass Screening
Neoplasm Staging
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - etiology
Ovarian Neoplasms - mortality
Ovarian Neoplasms - therapy
Physical Examination
Prognosis
Radioimmunodetection
Risk Factors
Survival Rate
Tomography, X-Ray Computed
title Recent advances in the detection of ovarian cancer: A review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T17%3A46%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20in%20the%20detection%20of%20ovarian%20cancer:%20A%20review&rft.jtitle=Journal%20of%20Osteopathic%20Medicine%20(Online)&rft.au=Blend,%20Michael%20J.&rft.date=1994-04-01&rft.volume=94&rft.issue=4&rft.spage=305&rft.epage=305&rft.pages=305-305&rft.issn=0098-6151&rft.eissn=2702-3648&rft_id=info:doi/10.7556/jaoa.1994.94.4.305&rft_dat=%3Cproquest_cross%3E76589720%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76589720&rft_id=info:pmid/8026999&rfr_iscdi=true